Seelos Therapeutics, Inc. Operating Lease Liability
Seelos Therapeutics, Inc. had Operating Lease Liability of $47.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-08-14
- 2024-06-30: Operating Lease, Liability $47.00K.
- 2024-03-31: Operating Lease, Liability $62.00K.
- 2023-12-31: Operating Lease, Liability $15.00K.
- 2023-09-30: Operating Lease, Liability $30.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-06-30 | $47.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $62.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $15.00K 10-K · filed 2024-03-06 |
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $46.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $60.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $73.00K 10-K · filed 2023-03-10 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $26.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $38.00K 10-K · filed 2022-03-04 |
| 2021-09-30 | $51.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $63.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $74.00K 10-Q · filed 2021-04-30 |